That, in itself, is remarkable
However, another randomized, double-blind, placebo-controlled trial in 181 patients with diabetic neuropathy found that oral supplementation with either 600 mg/day, 1,200 mg/day, or 1,800 mg/day of lipoic acid for five weeks significantly improved neuropathic symptoms (77)
We also have completed a randomized clinical trial on supplementing GlyNAC vs
Mounjaro (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities as an adjunct to reduced-calorie diet and increased physical activity
The intensity varies widelysome notice mild lightheadedness only when standing quickly, while others feel more pronounced vertigo